1 0

    FDA 483 and EIR for UCB Pharma S.A. Inspection Ending Feb 4, 2022 (FEI 3003909356)

    FDA 483 and EIR for UCB Pharma S.A. Inspection Ending Feb 4, 2022 (FEI 3003909356)

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: To Whom it May Concern: As permitted by the Freedom of Information Act (FOIA), I am hereby requesting the following document: Form FDA 483 & EIR UCB Pharma S.A Braine-L'alleud Belgium End Dates of inspection: 04 Feb 2022 Project Area: Drug Quality Assurance FEI: 3003909356 Investigator(s): Thuy T Nguyen, LCDR, Roger F Jose M Melendez Classification: VAI
    Tags: Pharma, 483, 2022
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details